Current Research:

My research interests include evaluating clinical outcomes of medications and examining factors that impact beneficial and adverse outcomes to medications under conditions of usual care. This would include pharmacoepidemiologic research as well as evaluations of drug treatment patterns, therapeutic effectiveness, and cost implications. I typically work with large datasets generated from medical health records and hospital administrative databases. Although my research cuts across many therapeutic topics, I have focused much of my work on psychiatric medications.

I have conducted studies on the comparative effectiveness, tolerability, and cost of the atypical antipsychotics. I've also examined emerging treatment patterns of these drugs in various populations such as the elderly. I recently collaborated with other faculty in the area of population pharmacokinetic modeling of antipsychotics. This work seeks to examine the relationship between antipsychotic dose and response and the impact of co-existing clinical, psychological, and social covariates. I am currently the principal investigator in a study investigating whether the use of a continuity of care record at the time of hospital discharge can reduce the number of medication-related discrepancies in community dwelling patients.

Bio:

Kim C. Coley, PharmD, FCCP is a Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy and Director of the Center for Pharmacoinformatics and Outcomes Research. She received her Bachelor of Science degree in pharmacy from the University of Pittsburgh and her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Science. Dr. Coley’s research focuses on evaluating clinical outcomes of medications and examining patient and system factors that impact beneficial and adverse outcomes to medications. Most recently, Dr. Coley is evaluating the impact of a continuity of care record at reducing medication discrepancies in community-dwelling patients after hospital discharge. Dr. Coley serves on several national pharmacy award panels and is a reviewer for numerous psychiatry and pharmacy journals.